News Focus
News Focus
icon url

DewDiligence

06/30/13 1:21 PM

#163225 RE: oc631 #163224

The ENTA/ABBV collaboration was in the slow lane until it became clear that all-oral HCV regimens would actually work. Then, the collaboration went into overdrive, which is what prompted ENTA to IPO.